VERISANTE TECHNOLOGY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VERISANTE TECHNOLOGY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: andre dallaire	4/17/2012 6:11:29 PM
	Read Replies (1) of 254

Verisante Technology, Inc. to be featured by CEO Clips airing on CBC News Network: April 17, 2012 CEO Clips profiles some of the most innovative publicly traded companies in North America and will feature a 15 to 30 second clip about Verisante Technology, Inc. on CBC News Network beginning April 16, 2012. The feature can also be viewed online via this link: http://www.b-tv.com/media/mp4/CDN_VerisanteTech30_2012.mp4 About CBC News Network: CBC News Network is a Canadian 24-hour news cable television channel which broadcasts to over 10 million homes in Canada and some northern states of the USA. It is the world's third-oldest television service of this nature, after CNN and Sky News. The Canadian Broadcasting Corporation (CBC) is Canada's national public broadcaster. About Verisante Technology, Inc. Verisante is a medical device company committed to commercializing innovative systems for the detection of cancer. The Verisante Aura<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> for skin cancer detection and the Verisante Core<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and tested and refined at the Skin Care Centre at Vancouver General Hospital. This exclusive platform technology allows Verisante to develop and offer a range of compact, non-invasive cancer detection devices that offer physicians immediate results for many of the most common cancers. The Aura<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> has been approved for sale in Canada, Europe and Australia. The Core<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> has not yet been approved for sale. Verisante Aura<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> was recently awarded Popular Science Magazine’s “Best of What’s New Award” for 2011, and Verisante Core<IMG class="Emoji2122$1539" title="Trademark symbol" alt="Trademark symbol" src="http://gfx1.hotmail.com/mail/w4/pr04/ltr/emoji/emoji_02122.gif"> was named one of the top 10 cancer breakthroughs of 2011 by the Canadian Cancer Society. In addition, the Company was named a finalist for the 2011 Regional Awards for New Technology by the Canadian Manufacturers & Exporters and the National Research Council of Canada and named as the year’s top ranking Technology and Life Sciences Company on the TSX Venture 50.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next